Growth Metrics

Allurion Technologies (ALUR) Net Income towards Common Stockholders (2022 - 2026)

Allurion Technologies posted quarterly Net Income towards Common Stockholders of -$6.1 million for Q1 2026, down 182.6% year-on-year from $7.4 million in Q1 2025, and down 126.48% on a QoQ basis from $23.0 million in Q4 2025.

Allurion Technologies (ALUR) has 5 years of Net Income towards Common Stockholders data on file, last reported at -$6.1 million in Q1 2026.

  • For the quarter ending Q1 2026, Net Income towards Common Stockholders fell 182.6% year-over-year to -$6.1 million; the trailing twelve-month figure through Mar 2026 stood at -$4.3 million (down 136.58% YoY), and the FY2025 full-year result was $347000.0, up 104.82% from the prior year.
  • Net Income towards Common Stockholders for Q1 2026 stood at -$6.1 million, down from $23.0 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $23.0 million in Q4 2025 and bottomed at -$22.7 million in Q2 2023.
  • The 5-year median for Net Income towards Common Stockholders is -$9.5 million (2024), against an average of -$7.6 million.
  • The widest annual swing landed in 2023, when Net Income towards Common Stockholders tumbled 270.65%; it then surged 339.59% in 2025.
  • A 5-year view of Net Income towards Common Stockholders shows it stood at -$13.1 million in 2022, then plunged by 63.53% to -$21.4 million in 2023, then soared by 55.08% to -$9.6 million in 2024, then surged by 339.59% to $23.0 million in 2025, then slumped by 126.48% to -$6.1 million in 2026.
  • The last three Net Income towards Common Stockholders figures came in at -$6.1 million (Q1 2026), $23.0 million (Q4 2025), and -$11.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 1.08 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 745.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 1.15 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 187,319.30
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 199.50 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 411.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Allurion Technologies - - 1.23 Mn -6.10 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -6.10 Mn
Dec 31, 2025 -6.48 Mn
Sep 30, 2025 -11.88 Mn
Jun 30, 2025 -9.34 Mn
Mar 31, 2025 1.21 Mn
Dec 31, 2024 -9.61 Mn
Sep 30, 2024 8.74 Mn
Jun 30, 2024 -8.32 Mn
Mar 31, 2024 2.00 Mn
Dec 31, 2023 -21.39 Mn
Sep 30, 2023 -21.89 Mn
Jun 30, 2023 -22.72 Mn
Mar 31, 2023 -18.52 Mn
Dec 31, 2022 -13.08 Mn
Sep 30, 2022 -14.31 Mn
Jun 30, 2022 -6.13 Mn